Get the Stockscreener App
14.04
2.02%
-0.29
After Hours:
14.04
Overview
News
Price History
Option Chain
Financials
Why FMC Down?
Discussions
Forecast
Stock Split
Dividend History
Fmc Corp stock is traded at $14.04, with a volume of 3.08M.
It is down -2.02% in the last 24 hours and down -2.09% over the past month.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
See More
Previous Close:
$14.33
Open:
$14.74
24h Volume:
3.08M
Relative Volume:
0.73
Market Cap:
$1.75B
Revenue:
$3.47B
Net Income/Loss:
$-2.20B
P/E Ratio:
-0.7845
EPS:
-17.8972
Net Cash Flow:
$-176.50M
1W Performance:
+0.00%
1M Performance:
-2.09%
6M Performance:
-63.40%
1Y Performance:
-65.23%
1-Day Range:
$14.03
$14.80
1-Week Range:
$13.51
$14.95
52-Week Range:
$12.17
$44.78
Fmc Corp Stock (FMC) Company Profile
Name
Fmc Corp
Sector
Industry
Phone
215-299-6668
Address
2929 WALNUT STREET, PHILADELPHIA, PA
Compare FMC vs CTVA, NTR, CF, MOS, ICL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FMC
Fmc Corp
|
14.04 | 1.75B | 3.47B | -2.20B | -176.50M | -17.90 |
|
CTVA
Corteva Inc
|
79.21 | 53.27B | 17.40B | 1.20B | 2.82B | 1.5836 |
|
NTR
Nutrien Ltd
|
82.85 | 39.86B | 26.89B | 2.30B | 2.01B | 4.6618 |
|
CF
Cf Industries Holdings Inc
|
129.57 | 19.91B | 7.08B | 1.80B | 1.80B | 8.9928 |
|
MOS
Mosaic Company
|
29.31 | 9.31B | 11.06B | 367.80M | 212.50M | 1.16 |
|
ICL
Icl Group Ltd
|
5.37 | 6.93B | 7.15B | 280.00M | 137.88M | 0.1749 |
Fmc Corp Stock (FMC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Nov-11-25 | Resumed | Wells Fargo | Equal Weight |
| Oct-31-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-31-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-14-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Jun-23-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-25-25 | Upgrade | Mizuho | Neutral → Outperform |
| Mar-13-25 | Initiated | Goldman | Buy |
| Feb-14-25 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Feb-07-25 | Downgrade | UBS | Buy → Neutral |
| Feb-05-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-21-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-14-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-23-24 | Initiated | Citigroup | Neutral |
| Jun-26-24 | Initiated | Barclays | Equal Weight |
| Mar-01-24 | Initiated | Wolfe Research | Peer Perform |
| Feb-12-24 | Downgrade | Loop Capital | Buy → Hold |
| Feb-07-24 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Jan-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-04-24 | Initiated | ROTH MKM | Buy |
| Dec-14-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-07-23 | Downgrade | Mizuho | Buy → Neutral |
| Oct-24-23 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-24-23 | Downgrade | Goldman | Buy → Neutral |
| Oct-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-16-23 | Upgrade | Vertical Research | Hold → Buy |
| Sep-25-23 | Downgrade | Redburn Atlantic | Overweight → Neutral |
| Sep-05-23 | Downgrade | UBS | Buy → Neutral |
| Aug-21-23 | Initiated | JP Morgan | Neutral |
| Aug-04-23 | Upgrade | Credit Suisse | Underperform → Neutral |
| Jul-24-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-17-23 | Upgrade | Redburn | Neutral → Buy |
| Jan-19-23 | Resumed | Wells Fargo | Overweight |
| Jan-10-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-15-22 | Upgrade | Loop Capital | Hold → Buy |
| Jul-20-22 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jun-21-22 | Upgrade | BofA Securities | Underperform → Buy |
| Jun-13-22 | Downgrade | Redburn | Buy → Neutral |
| May-31-22 | Initiated | Credit Suisse | Underperform |
| Apr-14-22 | Downgrade | Loop Capital | Buy → Hold |
| Mar-31-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| Mar-22-22 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-22 | Reiterated | Citigroup | Buy |
| Feb-10-22 | Reiterated | Mizuho | Buy |
| Feb-10-22 | Reiterated | Monness Crespi & Hardt | Buy |
| Feb-10-22 | Reiterated | Wells Fargo | Overweight |
| Jan-31-22 | Initiated | Redburn | Buy |
| Jan-11-22 | Upgrade | Citigroup | Neutral → Buy |
| Nov-29-21 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-18-21 | Upgrade | Loop Capital | Hold → Buy |
| Oct-13-21 | Initiated | Mizuho | Buy |
| Oct-11-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-24-21 | Downgrade | Vertical Research | Buy → Hold |
| May-06-21 | Downgrade | Citigroup | Buy → Neutral |
| Feb-11-21 | Upgrade | Monness Crespi & Hardt | Neutral → Buy |
| Sep-17-20 | Initiated | UBS | Buy |
| Mar-26-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Mar-13-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Oct-16-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-16-19 | Initiated | Wells Fargo | Outperform |
| Sep-18-19 | Initiated | Exane BNP Paribas | Outperform |
| Aug-09-19 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-02-19 | Upgrade | Goldman | Neutral → Buy |
| Aug-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-13-19 | Resumed | Citigroup | Buy |
| May-20-19 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-18-19 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-21-19 | Reiterated | Jefferies | Buy |
| Mar-08-19 | Resumed | Goldman | Neutral |
| Nov-14-18 | Initiated | Buckingham Research | Buy |
| Nov-09-18 | Resumed | Loop Capital | Buy |
| Nov-05-18 | Resumed | Citigroup | Buy |
| Nov-05-18 | Resumed | Credit Suisse | Outperform |
| May-14-18 | Upgrade | Goldman | Neutral → Buy |
| May-04-18 | Upgrade | Stephens | Equal-Weight → Overweight |
View All
Fmc Corp Stock (FMC) Latest News
FMC Corporation (NYSE:FMC) Growth Strategies Drive Market Activities NYSE Composite - Kalkine Media
FMC Corp Stock (ISIN: US3448491049) Hits Multi-Year Lows Amid Crop Protection Slump - AD HOC NEWS
FMC Corporation (NYSE:FMC) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
FMC Corp. Stock (ISIN: US3024913036) Faces Headwinds in Agricultural Chemicals Amid Pricing Pressure - AD HOC NEWS
FMC (NYSE:FMC) Stock Rating Upgraded by Wall Street Zen - MarketBeat
FMC CORP ($FMC) CEO 2025 Pay Revealed - Quiver Quantitative
FMC Corp. stock underperforms Friday when compared to competitors - MarketWatch
Governance shifts at FMC (NYSE: FMC) as board seeks end to supermajority votes and adds 2026 incentive stock plan - Stock Titan
FMC SEC FilingsFmc Corp 10-K, 10-Q, 8-K Forms - Stock Titan
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at J.P. Morgan Industrials Conference - Finviz
FMC's CEO and CFO take the stage at J.P. Morgan Industrials - Stock Titan
Biopesticides Gaining Momentum: BASF, Corteva, and FMC Signal a New Era for Biologicals - CropLife
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FMC CorporationFMC - ChartMill
Deal Dispatch: Nestlé Sells Blue Bottle; Netflix Buys Ben Affleck's InterPositive, Eddie Bauer Nixes Bankruptcy Auction - Benzinga
Insider Buying: Michael Barry Acquires Shares of FMC Corp - GuruFocus
Michael Barry Buys 18,072 Shares of FMC (NYSE:FMC) Stock - MarketBeat
FMC director Barry buys $249,938 in company stock By Investing.com - Investing.com Australia
FMC director Barry buys $249,938 in company stock - Investing.com
Insider Purchase: Director at $FMC Buys 18,072 Shares - Quiver Quantitative
[Form 4] FMC CORP Insider Trading Activity - Stock Titan
Barclays Maintains FMC Corp(FMC.US) With Sell Rating, Maintains Target Price $13 - 富途牛牛
FMC's GC Retired In 2025 With Over $6.6M In Compensation - Law360
FMC Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
J.P. Morgan Maintains FMC Corp(FMC.US) With Hold Rating, Raises Target Price to $15 - 富途牛牛
FMC Corp. stock underperforms Monday when compared to competitors - MarketWatch
2 Words That Should Make Investors Think Twice About FMC Stock - Yahoo Finance
FMC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can Pierre Brondeau save FMC, the global pesticide maker he put on Philly’s skyline? - Inquirer.com
FMC Corporation declares 8-cent quarterly dividend - Investing.com
Press Release: FMC Corporation Declares Quarterly Dividend - 富途牛牛
FMC Corporation Declares Quarterly Dividend - Finviz
FMC appoints Michael Barry to board of directors By Investing.com - Investing.com Canada
FMC appoints Michael Barry to board of directors - Investing.com
FMC Corporation Announces Election of Michael F. Barry to Board of Directors - Finviz
Ex-Quaker Houghton CEO who led 27 deals joins FMC's board - Stock Titan
FMC Corp Stock Re-Rates On Cost Cuts And Lawsuits: Opportunity Or Value Trap? - AD HOC NEWS
FMC CORP SEC 10-K Report - TradingView
FMC Corp. stock underperforms Thursday when compared to competitors - MarketWatch
2 Top Bargain Stocks Ready for a Bull Run - The Motley Fool
2 Top Bargain Stocks Ready for a Bull Run - The Motley Fool
Analysis of Insider Buying Activity at FMC Corp. - Intellectia AI
FMC Corp stock rises — what did the CEO say to drive rally? - MSN
FMC at Bank of America Conference: Strategic Plans Unveiled - Investing.com
FMC Corp Stock Rises — What Did The CEO Say To Drive Rally? - Asianet Newsable
FMC Considers Sale Process, Stock Rises 7% - Intellectia AI
FMC Corp. stock outperforms competitors on strong trading day - MarketWatch
FMC (NYSE: FMC) EVP Scanlan reports tax-withholding share disposition - Stock Titan
FMC Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
FMC’s Rimisoxafen Receives Historic Dual Mode of Action Classification from HRAC - iGrow News
FMC Corporation Receives Industry's First Dual Mode of Action Herbicide Classification for Rimisoxafen - Finviz
Cardinal Health and FMC Corporation have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Fmc Corp Stock (FMC) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.76%
2.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):